Table of Contents 1 Market Overview 1.1 Compounding Pharmacy Introduction 1.2 Market Analysis by Type 1.2.1 Pharmaceutical ingredient alteration ( PIA ) 1.2.2 Pharmaceutical application alteration ( PAA ) 1.2.3 Currently unavailable pharmaceutical manufacturing ( CUPM ) 1.2.4 Pharmaceutical dosage alteration ( PDA ) 1.2.5 Specialized animal pharmaceutical manufacturing ( SAPM ) 1.3 Market Analysis by Applications 1.3.1 Consumers aged 18 and younger 1.3.2 Consumers aged 19 to 44 1.3.3 Consumers aged 45 to 64 1.3.4 Consumers aged 65 and older 1.4 Market Analysis by Countries 1.4.1 United States Status and Prospect ( 2012-2022 ) 1.4.2 Mexico Status and Prospect ( 2012-2022 ) 1.4.3 Canada Status and Prospect ( 2012-2022 ) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Fagron 2.1.1 Profile 2.1.2 Compounding Pharmacy Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Fagron Compounding Pharmacy Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.1.4 Business Overview 2.1.5 Fagron News 2.2 Wedgewood Pharma 2.2.1 Profile 2.2.2 Compounding Pharmacy Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Wedgewood Pharma Compounding Pharmacy Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.2.4 Business Overview 2.2.5 Wedgewood Pharma News 2.3 CAPS 2.3.1 Profile 2.3.2 Compounding Pharmacy Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 CAPS Compounding Pharmacy Sales , Price , Revenue , Gross Margin and Market Share ( 2016-2017 ) 2.3.4 Business Overview 2.3.5 CAPS News